Viewing Study NCT01177956

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:37 PM
Ignite Modification Date: 2026-02-02 @ 5:19 AM
Study NCT ID: NCT01177956
Status: COMPLETED
Last Update Posted: 2014-09-03
First Post: 2010-06-02
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: A Trial to Determine the Safety and Anti-tumor Activity Profile of the Combination of Cetuximab and Concomitant Cisplatin Plus 5-Fluorouracil (5-FU) in Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma in Head and Neck
Sponsor: Merck KGaA, Darmstadt, Germany
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Squamous Cell Carcinoma of the Head and Neck View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Recurrent and/or metastatic squamous cell carcinoma of the head and … View
None 1st-line View
None Cetuximab View
None Chemotherapy View
None EMR 62241 -055 View
None Merck KGaA View
None Recurrent and/or metastatic squamous cell carcinoma of the head and … View